{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T20:13:12Z","timestamp":1773259992755,"version":"3.50.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,18]],"date-time":"2021-04-18T00:00:00Z","timestamp":1618704000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005911","name":"Najran University","doi-asserted-by":"publisher","award":["NU\/MID\/17\/113"],"award-info":[{"award-number":["NU\/MID\/17\/113"]}],"id":[{"id":"10.13039\/501100005911","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002383","name":"King Saud University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002383","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Saudi Pharmaceutical Journal"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.jsps.2021.04.011","type":"journal-article","created":{"date-parts":[[2021,4,23]],"date-time":"2021-04-23T07:49:42Z","timestamp":1619164182000},"page":"478-486","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Formulation of sublingual promethazine hydrochloride tablets for rapid relief of motion sickness"],"prefix":"10.1007","volume":"29","author":[{"given":"Hamad S","family":"Alyami","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed A.","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad H.","family":"Alyami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9815-3720","authenticated-orcid":false,"given":"Eman Z","family":"Dahmash","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osaid T.","family":"Almeanazel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9407-7185","authenticated-orcid":false,"given":"Thamer S","family":"Algahtani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fars","family":"Alanazi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Doaa H.","family":"Alshora","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"issue":"2","key":"10.1016\/j.jsps.2021.04.011_b0005","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1097\/00007691-200304000-00008","article-title":"Histamine H1-receptor antagonists, promethazine and homochlorcyclizine, increase the steady-state plasma concentrations of haloperidol and reduced haloperidol","volume":"25","author":"Suzuki","year":"2003","journal-title":"Ther. Drug Monit."},{"issue":"2","key":"10.1016\/j.jsps.2021.04.011_b0010","first-page":"193","article-title":"Antiemetic efficacy of promethazine on xylazine-induced emesis in cats","volume":"53","author":"Kolahian","year":"2012","journal-title":"Can. Vet. J."},{"issue":"2","key":"10.1016\/j.jsps.2021.04.011_b0015","first-page":"113","article-title":"Nausea and vomiting in pregnancy: a review of the pathology and compounding opportunities","volume":"17","author":"Zur","year":"2013","journal-title":"Int. J. Pharm. Compd."},{"issue":"12","key":"10.1016\/j.jsps.2021.04.011_b0020","doi-asserted-by":"crossref","DOI":"10.1345\/aph.1R484","article-title":"Gastroparesis-associated refractory nausea treated with aprepitant","volume":"46","author":"Fahler","year":"2012","journal-title":"Ann. Pharmacother."},{"issue":"4","key":"10.1016\/j.jsps.2021.04.011_b0025","doi-asserted-by":"crossref","first-page":"186","DOI":"10.3390\/pharmacy8040186","article-title":"Recent Formulation Advances and Therapeutic Usefulness of Orally Disintegrating Tablets (ODTs)","volume":"8","author":"Chinwala","year":"2020","journal-title":"Pharmacy"},{"issue":"11","key":"10.1016\/j.jsps.2021.04.011_b0030","first-page":"273","article-title":"Formulation and in vitro evaluation of in situ gelling liquid suppository of promethazine HCl","volume":"4","author":"Deshmukh","year":"2015","journal-title":"World J. Pharm. Res."},{"issue":"5","key":"10.1016\/j.jsps.2021.04.011_b0035","doi-asserted-by":"crossref","first-page":"149","DOI":"10.22270\/jddt.v10i5.4393","article-title":"Fixed Dose Oral Dispersible Tablet of Bitter Drug Using Okra Mucilage: Formulation and Evaluation","volume":"10","author":"Dhar","year":"2020","journal-title":"J. Drug Delivery Therapeut."},{"issue":"2","key":"10.1016\/j.jsps.2021.04.011_b0040","first-page":"660","article-title":"Formulation and evaluation of oral fast dissolving tablets of promethazine HCL by sublimation method","volume":"3","author":"Kavitha","year":"2011","journal-title":"Int. J. PharmTech Res."},{"issue":"11","key":"10.1016\/j.jsps.2021.04.011_b0045","doi-asserted-by":"crossref","first-page":"01","DOI":"10.9790\/3013-031101-11","article-title":"Formulation and Evaluation of Taste Masked Fast Disintegrating Tablet of Promethazine Hydrochloride","volume":"03","author":"Kolhe","year":"2013","journal-title":"IOSR J. Pharm. (IOSRPHR)"},{"key":"10.1016\/j.jsps.2021.04.011_b0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119912","article-title":"Advances in drug delivery systems: Work in progress still needed?","author":"Laffleur","year":"2020","journal-title":"Int. J. Pharm. X"},{"issue":"8","key":"10.1016\/j.jsps.2021.04.011_b0055","doi-asserted-by":"crossref","first-page":"18","DOI":"10.46624\/ajphr.2020.v8.i8.002","article-title":"Formulation Development and Evaluation of Promethazine As A Lozenge","volume":"8","author":"Mallappa","year":"2020","journal-title":"American J. Pharm. Health Res."},{"issue":"5","key":"10.1016\/j.jsps.2021.04.011_b0060","first-page":"399","article-title":"Sublingual Drug Delivery System : a novel approach","volume":"10","author":"Nayak","year":"2017","journal-title":"Int. J. Pharm. Drug Anal."},{"key":"10.1016\/j.jsps.2021.04.011_b0065","unstructured":"Vishakha, C. et al., 2019 \u2018Formulation and evaluation of sublingual tablet of Venlafaxine hydrochloride for the treatment of depression\u2019, Journal of Drug Delivery and Therapeutics, 9(2-A), pp. 56\u201358. Available at: http:\/\/jddtonline.info\/index.php\/jddt\/article\/view\/2779."},{"key":"10.1016\/j.jsps.2021.04.011_b0070","first-page":"1","article-title":"Evaluation of Matrix Tablets Based on Eudragit\u00aeE100\/Carbopol\u00ae971P Combinations for Controlled Release and Improved Compaction Properties of Water Soluble Model Drug Paracetamol","volume":"2","author":"Obeidat","year":"2015","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.jsps.2021.04.011_b0075","doi-asserted-by":"crossref","first-page":"235","DOI":"10.4103\/0973-8398.45038","article-title":"Effect of some physical parameters and crospovidone on directly compressed frusemide tablets","volume":"10\u201312","author":"Chaulang","year":"2008","journal-title":"Asian J. Pharmaceut."},{"key":"10.1016\/j.jsps.2021.04.011_b0080","first-page":"1","article-title":"Application of a quality-by-design approach for utilizing sodium stearyl fumarate as a taste-masking agent in dextromethorphan hydrobromide orally disintegrating tablets","volume":"1","author":"Mahrous","year":"2019","journal-title":"Pharm. Dev. Technol."},{"issue":"4","key":"10.1016\/j.jsps.2021.04.011_b0085","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1248\/bpb.25.541","article-title":"The Effect of Tablet Formulation and Hardness on in Vitro Release of Cephalexin from Eudragit L100 Based Extended Release Tablets","volume":"25","author":"Saravanan","year":"2002","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.jsps.2021.04.011_b0090","first-page":"4042","article-title":"Evaluation and comparison of highly soluble sodium stearyl fumarate with other lubricants in-vitro","volume":"5","author":"Kanugo","year":"2013","journal-title":"Indo Am. J. Pharm. Res."},{"key":"10.1016\/j.jsps.2021.04.011_b0095","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.ejpb.2008.02.016","article-title":"Effect of the type of lubricant on the characteristics of orally disintegrating tablets manufactured using the phase transition of sugar alcohol","volume":"69","author":"Kuno","year":"2008","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jsps.2021.04.011_b0100","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3390\/lubricants2010021","article-title":"Lubricants in pharmaceutical solid dosage forms","volume":"2","author":"Li","year":"2014","journal-title":"Lubricants"},{"key":"10.1016\/j.jsps.2021.04.011_b0105","doi-asserted-by":"crossref","unstructured":"Ibrahim, MA, Abou El Ela, AESF. Optimized furosemide taste masked orally disintegrating tablets. Saudi Pharm J. 2017 (25)1055-1062.","DOI":"10.1016\/j.jsps.2017.04.002"},{"key":"10.1016\/j.jsps.2021.04.011_b0110","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1590\/S1984-82502016000200009","article-title":"Formulation and evaluation of orally disintegrating clopidogrel tablets","volume":"2","author":"Mahrous","year":"2016","journal-title":"Brazil. J. Pharm. Sci."},{"key":"10.1016\/j.jsps.2021.04.011_b0115","unstructured":"United States Pharmacopiea, USP 35, \u30081216\u3009 monograph of tablet friability."},{"key":"10.1016\/j.jsps.2021.04.011_b0120","unstructured":"United States Pharmacopoeia; USP 34 harmonized monograph."},{"issue":"2","key":"10.1016\/j.jsps.2021.04.011_b0125","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1208\/s12249-010-9402-3","article-title":"An electronic tongue: evaluation of the masking efficacy of sweetening and\/or flavoring agents on the bitter taste of epinephrine","volume":"11","author":"Rachid","year":"2010","journal-title":"AAPS PharmSciTech"},{"issue":"2","key":"10.1016\/j.jsps.2021.04.011_b0130","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1208\/s12249-011-9615-0","article-title":"Dissolution testing of sublingual tablets: a novel in vitro method","volume":"12","author":"Rachid","year":"2011","journal-title":"AAPS PharmSciTech."},{"key":"10.1016\/j.jsps.2021.04.011_b0135","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.ejpb.2012.05.020","article-title":"Rapidly-disintegrating sublingual tablets of epinephrine: role of non-medicinal ingredients in formulation development","volume":"3","author":"Rachid","year":"2012","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"2","key":"10.1016\/j.jsps.2021.04.011_b0140","doi-asserted-by":"crossref","first-page":"454","DOI":"10.3109\/10837450.2012.710237","article-title":"Development and optimization of dextromethorphan hydrobromide oral disintegrating tablets: effect of formulation and process variables","volume":"18","author":"Mostafa","year":"2012","journal-title":"Pharm. Dev. Technol."},{"issue":"1","key":"10.1016\/j.jsps.2021.04.011_b0145","first-page":"1","article-title":"Sublingual Route During Perioperative and Chronic Pain Management","volume":"3","author":"Garg","year":"2015","journal-title":"J. Anesth. Crit. Care."},{"issue":"2","key":"10.1016\/j.jsps.2021.04.011_b0150","first-page":"193","article-title":"Studies of Rapidly Disintegrating tablets in the oral cavity using co-ground mixtures of mannitol with crospovidone","volume":"50","author":"Shu","year":"2002","journal-title":"ChemPharma Bull."},{"issue":"3","key":"10.1016\/j.jsps.2021.04.011_b0155","first-page":"257","article-title":"Why is mannitol becoming more and more popular as a pharmaceutical excipient in solid dosage forms?","volume":"19","author":"Ohrem","year":"2013","journal-title":"Pharm. DevTechnol"},{"key":"10.1016\/j.jsps.2021.04.011_b0165","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ejps.2018.02.013","article-title":"Systematic evaluation of common lubricants for optimal use in tablet formulation","volume":"117","author":"Paul","year":"2018","journal-title":"Eur. J. Pharm. Sci."},{"issue":"1\u20132","key":"10.1016\/j.jsps.2021.04.011_b0160","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ijpharm.2009.08.010","article-title":"A new formulation for orally disintegrating tablets using a suspension spray-coating method","volume":"382","author":"Okuda","year":"2009","journal-title":"Int. J. Pharm."}],"container-title":["Saudi Pharmaceutical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1319016421000682?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1319016421000682?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T17:25:52Z","timestamp":1736184352000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1319016421000682"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":33,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["S1319016421000682"],"URL":"https:\/\/doi.org\/10.1016\/j.jsps.2021.04.011","relation":{},"ISSN":["1319-0164"],"issn-type":[{"value":"1319-0164","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Formulation of sublingual promethazine hydrochloride tablets for rapid relief of motion sickness","name":"articletitle","label":"Article Title"},{"value":"Saudi Pharmaceutical Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsps.2021.04.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier B.V. on behalf of King Saud University.","name":"copyright","label":"Copyright"}]}}